Charles River Laboratories | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
Agilent USD 6.03B 129M 2025-01
Align Technology USD 3.79B 57.74M 2025-03
Bio-Rad Laboratories USD 6.68B 110.1M 2025-03
Bruker USD 1.83B 35.8M 2025-03
Cardinal Health USD -2948000000 43M 2025-03
Charles River Laboratories USD 3.19B 267.17M 2025-03
Cigna USD 40.23B 807M 2025-03
CVS Health USD 76.93B 1.37B 2025-03
Danaher USD 50.85B 1.31B 2025-03
Dentsply International USD 1.94B 549M 2024-12
Elevance Health USD 42.5B 1.19B 2025-03
Galapagos EUR 2.75B 149.05M 2025-03
Hologic USD 4.62B 154.6M 2025-03
Humana USD 17.75B 1.38B 2025-03
Illumina USD 2.37B 248M 2024-12
Incyte USD 3.67B 219.94M 2025-03
IQVIA Holdings USD 5.98B 90M 2025-03
Laboratory Of America USD 8.32B 269.5M 2025-03
Lonza CHF 9.33B 23M 2024-12
McKesson USD -3084000000 67M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Mettler Toledo International USD -181982000 55.09M 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Quest Diagnostics USD 6.93B 151M 2025-03
Revvity USD 7.64B 29.74M 2025-03
Thermo Fisher Scientific USD 49.36B 227M 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03
UnitedHealth USD 100.81B 8.15B 2025-03
Walgreens Boots Alliance USD 7.11B 2.83B 2025-02
Waters USD 1.96B 133.89M 2025-03
West Pharmaceutical Services USD 2.68B 800K 2025-03



Charles River Laboratories رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.